Fitness Trends Global CAR T Cell Therapy Market | Page 3

Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/102
Market players are engaged in developing and launching innovative products and adopt merger
and acquisition strategies to retain position in the global CAR-T cell therapy market
Key players in the market are engaged in extensive research and development to launch new
targeted cell therapies in the market. For instance, the University of Texas MD Anderson Cancer
Center, Houston is conducting phase 1 clinical trial studies of central memory–derived CD19
CAR T–cell therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma. Moreover,
key players are focusing on strategic merger and acquisition to enhance their share in the
global CAR-T cell therapy market. For instance, in April 2018, Pfizer, Inc. signed a deal with
Allogene, to develop an investigational CAR-T cell therapy for treating cancer.
Key players operating in the global CAR-T cell therapy market include Novartis International
AG, Kite Pharma, Inc. (Gilead Sciences, Inc.), Juno Therapeutics (Celgene Corporation), Bluebird
Bio, Inc. (Celgene Corporation), Sorrento Therapeutics Inc., Mustang Bio, Inc., Aurora
Biopharma Inc., Legend Biotech (Genscript Biotech Corporation), Pfizer, Inc., CARsgen
Therapeutics, Ltd., and others.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: [phone]
Email: [e-mail]